上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1327Please respect copyright.PENANAmKTOHylVNn
1327Please respect copyright.PENANAPJaEZbwTGl
上集:https://www.penana.com/article/4711251327Please respect copyright.PENANAB22Btaj1mI
1327Please respect copyright.PENANADt8yF1CvfU1327Please respect copyright.PENANAFfad6eGMkx
1327Please respect copyright.PENANAVc6GqVcBlf
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1327Please respect copyright.PENANAaynd1QFKh0
1327Please respect copyright.PENANAl73Vqy2oB4
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1327Please respect copyright.PENANAQa9DpafSXS
1327Please respect copyright.PENANA6Frh7zKouO
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1327Please respect copyright.PENANAn5MO2Ge9xX
1327Please respect copyright.PENANAKrmGnQ5WAe1327Please respect copyright.PENANAP1IoPJXkUb
1327Please respect copyright.PENANAetTuK0Z4Cw
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1327Please respect copyright.PENANAmI56aoLjcb
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1327Please respect copyright.PENANAH0SBAq2HvS
1327Please respect copyright.PENANAe6eCJjGJAj
忘記甚麼是Neoantigen的話,可重溫上一集。1327Please respect copyright.PENANAGb4YCYnYfX
1327Please respect copyright.PENANAhxBTpmPLHF
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1327Please respect copyright.PENANA1TLIhWNpZs
1327Please respect copyright.PENANACOfLc0KFF0
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1327Please respect copyright.PENANAMvrlMQQsZF
1327Please respect copyright.PENANAwgqGjge59T1327Please respect copyright.PENANAL8kasPIa0F
1327Please respect copyright.PENANAZTxcj3rolL
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1327Please respect copyright.PENANAXPUFYZykxt
1327Please respect copyright.PENANAJL6RRorGKk
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1327Please respect copyright.PENANAMZOoWuTqab
1327Please respect copyright.PENANAZAmbVCDiXi
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1327Please respect copyright.PENANAb63w5gHoku1327Please respect copyright.PENANAFSs5XVuDTL
1327Please respect copyright.PENANADJW7IbsI0B
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1327Please respect copyright.PENANAFqEH9jTcsl
1327Please respect copyright.PENANAJ7FYnx7ks5
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1327Please respect copyright.PENANA5EASznAPUl1327Please respect copyright.PENANA5pBDP0BXQZ
1327Please respect copyright.PENANAyRpe2R1Q0L
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1327Please respect copyright.PENANAXybeheTBUy
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1327Please respect copyright.PENANAZnnErcxy65
1327Please respect copyright.PENANA86hPCh5LOc
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1327Please respect copyright.PENANAOZQ1x9gSPG
1327Please respect copyright.PENANAsM4fmqSyFY
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1327Please respect copyright.PENANAJU0mzIBHTy
1327Please respect copyright.PENANA3i9cNxEGcs
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1327Please respect copyright.PENANAz70P8ZWuYw
1327Please respect copyright.PENANAdnDRMbdWAC
1327Please respect copyright.PENANA0TgYcWeKmA
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1327Please respect copyright.PENANAOAws6zsnyf
1327Please respect copyright.PENANARJVxDW4Pam
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1327Please respect copyright.PENANADtCHDd2DQD
1327Please respect copyright.PENANAgu0mRGXico
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1327Please respect copyright.PENANAO0D6Yyy7UW
1327Please respect copyright.PENANABKZ6cdy7zR
Link:1327Please respect copyright.PENANA85X71RXT83
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1327Please respect copyright.PENANA44GCFFI1Ky
1327Please respect copyright.PENANAIlTJV8jCdp
1327Please respect copyright.PENANAdz5s67vdHM
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1327Please respect copyright.PENANA8dGU4P03sz